BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31980307)

  • 1. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma.
    Chen W; Ma T; Zhang J; Zhang X; Chen W; Shen Y; Bai X; Liang T
    HPB (Oxford); 2020 Jun; 22(6):795-808. PubMed ID: 31980307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ
    Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Shen A; Liu M; Zheng D; Chen Q; Wu Z
    Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):142-154. PubMed ID: 31303533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Adjuvant Transarterial Chemoembolization after Radical Hepatectomy in Solitary Hepatocellular Carcinoma Patients: A Retrospective Study.
    Zeng G; Zou B; Li Y; Lin E; Liu X; Li P; Chen J; Zhang B; Jia Y; Cai C; Li J
    J Invest Surg; 2022 Jun; 35(6):1208-1216. PubMed ID: 35078386
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
    Yang J; Liang H; Hu K; Xiong Z; Cao M; Zhong Z; Yao Z; Deng M
    Cancer Cell Int; 2021 Feb; 21(1):92. PubMed ID: 33549093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis.
    Wang L; Ke Q; Lin N; Zeng Y; Liu J
    Scand J Gastroenterol; 2019 May; 54(5):528-537. PubMed ID: 31081401
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion.
    Wang YY; Wang LJ; Xu D; Liu M; Wang HW; Wang K; Zhu X; Xing BC
    HPB (Oxford); 2019 Apr; 21(4):425-433. PubMed ID: 30249510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma.
    Feng X; Feng GY; Tao J; Ao YP; Wu XH; Qi SG; Shi ZR
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10505-10518. PubMed ID: 37284841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.
    Wang H; Du PC; Wu MC; Cong WM
    Hepatobiliary Surg Nutr; 2018 Dec; 7(6):418-428. PubMed ID: 30652086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell.
    Zhang J; Peng H; Wang B; Luo L; Cheng Y; He G; Tang Y; Pan M
    J Gastrointest Surg; 2021 Jul; 25(7):1770-1778. PubMed ID: 32748340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.
    Liao M; Zhu Z; Wang H; Huang J
    Scand J Gastroenterol; 2017; 52(6-7):624-634. PubMed ID: 28276833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort.
    Luo L; Shan R; Cui L; Wu Z; Qian J; Tu S; Zhang W; Xiong Y; Lin W; Tang H; Zhang Y; Zhu J; Huang Z; Li Z; Mao S; Li H; Hu Z; Peng P; He K; Li Y; Liu L; Shen W; He Y
    United European Gastroenterol J; 2023 Mar; 11(2):228-241. PubMed ID: 36905230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety.
    Wei W; Jian PE; Li SH; Guo ZX; Zhang YF; Ling YH; Lin XJ; Xu L; Shi M; Zheng L; Chen MS; Guo RP
    Cancer Commun (Lond); 2018 Oct; 38(1):61. PubMed ID: 30305149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion.
    Qi YP; Zhong JH; Liang ZY; Zhang J; Chen B; Chen CZ; Li LQ; Xiang BD
    Am J Surg; 2019 Apr; 217(4):739-744. PubMed ID: 30103903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis.
    Liang L; Li C; Diao YK; Jia HD; Xing H; Pawlik TM; Lau WY; Shen F; Huang DS; Zhang CW; Yang T
    Therap Adv Gastroenterol; 2020; 13():1756284820977693. PubMed ID: 33329759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel stratification scheme combined with internal arteries in CT imaging for guiding postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a retrospective cohort study.
    Li X; Liang X; Li Z; Liang J; Qi Z; Zhong L; Geng Z; Liang W; Quan X; Liang C; Liu Z
    Int J Surg; 2024 May; 110(5):2556-2567. PubMed ID: 38377071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative transarterial chemoembolization (TACE) + liver resection versus upfront liver resection for large hepatocellular carcinoma (≥5 cm): a systematic review and meta-analysis.
    Chan KS; Tay WX; Cheo FY; Shelat VG
    Acta Chir Belg; 2023 Dec; 123(6):601-617. PubMed ID: 37681991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.